跳至主要内容
临床试验/NL-OMON46593
NL-OMON46593招募中不适用

Effects of transcutaneous pulsed radiofrequency on patients with advanced cancer - Transcutaneous pulsed radiofrequency applied to cancer patients

Radboud Universitair Medisch Centrum0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) >= 18 years of age;
  • 2) patients with advanced-stage colorectal, breast, prostate or ovarian cancer;
  • 3) presently no longer responding to systemic treatment, and no other standard oncological treatment can be applied anymore (i.e. a patient is strictly in a clear palliative trajectory).
  • 4) history of tumor marker corresponding with disease progression on imaging;
  • 5) history of tumor marker responding to previous oncological treatment;
  • 6) patients able and willing to give written informed consent and comply with the requirement of the study protocol;
  • 7) life expectancy at least 3 months.

排除标准

  • 1) treatment with any cancer therapy, including but not limited to chemotherapy and radiation therapy, within 4 weeks before baseline;
  • 2) in the use of critical measuring devices, large metal implants or active implants like a pacemaker;
  • 3) pregnant.

研究者

相似试验